ES2861431T3 - Composiciones para el tratamiento de la rosácea - Google Patents

Composiciones para el tratamiento de la rosácea Download PDF

Info

Publication number
ES2861431T3
ES2861431T3 ES12805780T ES12805780T ES2861431T3 ES 2861431 T3 ES2861431 T3 ES 2861431T3 ES 12805780 T ES12805780 T ES 12805780T ES 12805780 T ES12805780 T ES 12805780T ES 2861431 T3 ES2861431 T3 ES 2861431T3
Authority
ES
Spain
Prior art keywords
composition
use according
rosacea
oil
bpo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12805780T
Other languages
English (en)
Spanish (es)
Inventor
Hanan Sertchook
Ofer Toledano
Haim Bar-Simantov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sol-Gel Technologies Ltd
Original Assignee
Sol-Gel Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sol-Gel Technologies Ltd filed Critical Sol-Gel Technologies Ltd
Application granted granted Critical
Publication of ES2861431T3 publication Critical patent/ES2861431T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES12805780T 2012-11-27 2012-11-27 Composiciones para el tratamiento de la rosácea Active ES2861431T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IL2012/050479 WO2014083557A1 (en) 2012-11-27 2012-11-27 Compositions for the treatment of rosacea

Publications (1)

Publication Number Publication Date
ES2861431T3 true ES2861431T3 (es) 2021-10-06

Family

ID=47428789

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12805780T Active ES2861431T3 (es) 2012-11-27 2012-11-27 Composiciones para el tratamiento de la rosácea

Country Status (7)

Country Link
EP (1) EP2925296B1 (enExample)
JP (1) JP6423355B2 (enExample)
CN (2) CN108159425A (enExample)
CA (2) CA2889199C (enExample)
ES (1) ES2861431T3 (enExample)
MX (1) MX376183B (enExample)
WO (1) WO2014083557A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017068673A1 (ja) * 2015-10-21 2017-04-27 マルホ株式会社 皮膚用の医薬組成物
US11622929B2 (en) 2016-03-08 2023-04-11 Living Proof, Inc. Long lasting cosmetic compositions
HUE073201T2 (hu) * 2017-07-12 2026-01-28 Sol Gel Tech Ltd Kapszulázott tretinoint tartalmazó készítmények
US10987300B2 (en) 2017-09-13 2021-04-27 Living Proof, Inc. Long lasting cosmetic compositions
US10842729B2 (en) 2017-09-13 2020-11-24 Living Proof, Inc. Color protectant compositions
AU2018370210B2 (en) 2017-11-20 2024-09-26 Living Proof, Inc. Properties for achieving long-lasting cosmetic performance
BR112020021902B1 (pt) 2018-04-27 2024-02-20 Living Proof, Inc Composições cosméticas de poliuretano-ureia para tratamento capilar, método de preservação da ondulação no cabelo humano e os usos de poliuretano-ureia
EP3586849A1 (en) * 2018-06-29 2020-01-01 Aprofol AG Folate preparations
JP6811213B2 (ja) * 2018-07-03 2021-01-13 ソル − ゲル テクノロジーズ リミテッド 酒さの治療のための組成物
US11628155B2 (en) 2019-02-19 2023-04-18 Sol-Gel Technologies Ltd. Method for therapeutic treatment of rosacea

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1335693A2 (en) * 2000-04-21 2003-08-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
GB0301577D0 (en) * 2003-01-23 2003-02-26 Edko Pazarlama Tanitim Ltd Sti Topical pharmaceutical and/or cosmetic dispense systems
FR2886850B1 (fr) 2005-06-10 2007-10-05 Galderma Sa Composition a base d'une avermectine et de peroxyde de benzoyle notamment pour le traitement de la rosacee
WO2008057411A1 (en) * 2006-11-02 2008-05-15 Stiefel Laboratories, Inc. Kits containing benzoyl peroxide pads and another acne-treating composition, and formulations and methods of use therefor
FR2909000B1 (fr) * 2006-11-28 2009-02-06 Galderma Res & Dev S N C Snc Compositions comprenant du peroxyde de benzoyle, au moins un derive de l'acide naphtoique et au moins un compose de type polymeres de polyurethane ou des derives de celui-ci, et leurs utilisations.
FR2910320B1 (fr) * 2006-12-21 2009-02-13 Galderma Res & Dev S N C Snc Emulsion comprenant au moins un retinoide et du peroxyde de benzole
ES2763829T3 (es) * 2007-02-01 2020-06-01 Sol Gel Tech Ltd Método para preparar partículas que comprenden un revestimiento de óxido de metal
EA200970724A1 (ru) * 2007-02-01 2010-02-26 Сол-Джел Текнолоджиз Лтд. Композиции для местного применения, содержащие пероксид и ретиноид
CN105287484A (zh) * 2007-11-30 2016-02-03 盖尔德马研究及发展公司 含有萘甲酸衍生物、过氧化苯甲酰和成膜剂的组合物
ES2773931T3 (es) * 2008-06-05 2020-07-15 Bausch Health Ireland Ltd Formulaciones farmacéuticas tópicas que contienen una baja concentración de peróxido de benzoílo en suspensión en agua y un solvente orgánico miscible en agua
KR20110084151A (ko) * 2008-07-31 2011-07-21 솔-겔 테크놀로지스 리미티드 활성성분을 포함하는 마이크로캡슐 및 금속 산화물 쉘, 그의 제조방법 및 그의 용도
JP2012514593A (ja) * 2009-01-05 2012-06-28 ゾル−ゲル テクノロジー リミテッド 被覆した活性剤を含む局所組成物
CA2777489C (en) * 2009-10-21 2018-11-20 Dow Pharmaceutical Sciences, Inc. Method for wetting a powder containing benzoyl peroxide
KR20130008002A (ko) * 2009-12-31 2013-01-21 솔-겔 테크놀로지스 리미티드 코어 안정화 마이크로캡슐, 이의 제조방법 및 이의 용도
US20120064135A1 (en) * 2010-09-15 2012-03-15 Norac Pharma Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof

Also Published As

Publication number Publication date
MX2015005515A (es) 2015-07-17
CN104853746A (zh) 2015-08-19
CA3051403A1 (en) 2014-06-05
CA3051403C (en) 2021-07-20
MX376183B (es) 2025-03-07
CA2889199A1 (en) 2014-06-05
EP2925296A1 (en) 2015-10-07
JP2016501205A (ja) 2016-01-18
CA2889199C (en) 2020-05-19
WO2014083557A1 (en) 2014-06-05
CN104853746B (zh) 2018-02-23
JP6423355B2 (ja) 2018-11-14
EP2925296B1 (en) 2021-01-06
CN108159425A (zh) 2018-06-15

Similar Documents

Publication Publication Date Title
US20200405665A1 (en) Methods for the treatment of rosacea
EP2925296B1 (en) Compositions for the treatment of rosacea
ES2912051T3 (es) Composiciones para aplicación tópica que comprenden un peróxido y retinoide
ES2369244T3 (es) Sistemas estables de nanocápsulas para la administración de moléculas activas.
US12295935B2 (en) Method for therapeutic treatment of rosacea
CN102458378A (zh) 用于递送活性化合物的胶态系统的制备方法
CN104606085A (zh) 一种新型高效抗菌的醋酸洗必泰纳米乳漱口液及其制备方法
JP6811213B2 (ja) 酒さの治療のための組成物